Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
263,222,327
-
Total 13F shares
-
15,103,338
-
Share change
-
+2,477,404
-
Total reported value
-
$145,886,918
-
Put/Call ratio
-
99%
-
Price per share
-
$9.66
-
Number of holders
-
80
-
Value change
-
+$23,189,587
-
Number of buys
-
50
-
Number of sells
-
26
Institutional Holders of Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) as of Q3 2015
As of 30 Sep 2015,
Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,103,338 shares.
The largest 10 holders included
EAGLE ASSET MANAGEMENT INC, FMR LLC, Novo A/S, BlackRock Fund Advisors, VANGUARD GROUP INC, Visium Asset Management, LP, BlackRock Institutional Trust Company, N.A., STIFEL FINANCIAL CORP, Marshall Wace LLP, and BANK OF AMERICA CORP /DE/.
This page lists
80
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.